Romania – Pharmaceutical products – Framework agreement for the supply of medicines I

Opportunity description

Supply of medicines Number of days before the deadline for submission of tenders/applications by which clarifications may be requested:18 The contracting authority's deadline for responding to requests for clarification submitted by economic operators is the 11th day before the deadline for submission of tenders. If the contracting authority is selected for the ex-ante review of the contract, pursuant to Emergency Ordinance No. 98/2017, as subsequently amended and supplemented, it will make the consolidated responses to requests for clarification available to the persons authorized by ANAP through the review decision before uploading and publishing them in the Electronic Public Procurement System, at least 4 days before the response deadline established in the contract notice, in accordance with the provisions of Article 8 of Annex No. 1 to Government Decision No. 419/2018 ACETAZOLAMIDA 250MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ACETILCISTEINA 200 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ACIDUM ASCORBICUM 500 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ACIDUM FOLICUM 5 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ACIDUM GADOBENICUM 529mg/ml SOL. INJ. 15 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ACIDUM TRANEXAMICUM SOL. INJ. 100 mg/ml 5 ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ACIDUM VALPROICUM + SARURI 57,64 mg/ ml 150 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ADENOSINUM SOL. INJ./PERF. 10mg/2ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Airless with BIOTITUS® Ointment -Original formula -50 ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ALBENDAZOLUM 200 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ALBENDAZOLUM 400mg/10ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ALLOPURINOL 100 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ALPRAZOLAMUM 1 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. AMOXICILLINUM + ACIDUM CLAVULANICUM 400mg / 57 mg / 5ml 70 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. APPLICATOR WITH BIOTITUS OINTMENT 15 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. APPLICATOR WITH BIOTITUS OINTMENT 32 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. AZITHROMYCINUM 500 MG PULB. PT. SOL. PERF. The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BENZATHINI BENZYLPENICILLINUM 1200000UI 10 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BETAMETHASONUM 1ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BIEN DORMIR MAX EXTENDED 7 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BIOTITUS ADEFIX ADHESIVE DRESSING 10*15 CM The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BIOTITUS ADEFIX ADHESIVE DRESSING 20*15 CM The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BRIVARACETAMUM 10 mg/ml SOL INJ./PERF. - 5 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BROMAZEPAMUM 3 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BROMOCRIPTINUM 2.5 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BUPROPIONUM 150 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BUTYLSCOPOLAMMONII BROMIDUM 20mg/ml 1 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CABERGOLINA 0.5 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CARBETOCINUM 100MCG/ML-1ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CARIPRAZINUM 1.5mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CEFPODOXIMUM 8mg/ml 100ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CELECOXIBUM 200 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CICLOSPORINUM 50MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Citronac-KD sachets The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CLOMIPRAMINUM 25 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CLONIDIN -RADIOPHARM 150 MCG / ML 1 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CLORCHINALDOL 100 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CLOZAPINUM 25mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COLECALCIFEROLUM 0.5mg/ml 10 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (CLORMADINONA + ETINILESTRADIOL) 2 mg/0,03 mg BELARA The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (DESOGESTRELUM + ETINILESTRADIO LUM) 150 micrograms/2 0 micrograms - NOVYNETTE The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (DESOGESTRELUM + ETINILESTRADIO LUM) 0,15 mg/0,03 mg - DESORELLE The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (DROSPIRENONUM + ESTETROLUM) 3 mg/14,2 mg - DROVELIS The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (ETINILESTRADIOLUM + CYPROTERONUM) 0,035 mg/2 mg - DIANE The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (ETINILESTRADIOLUM + DROSPIRENO NUM) 0,03 mg/3 mg MIDIANA DAILY The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (COAGULATION FACTORS) BERIPLEX P/N 1000 UI PULB + SOL V. PT. SOL. INJ. The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (FIBRINOGEN + THROMBIN) - TACHOSIL 9.5 x 4.8 x 0.5 cm The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (GESTODENUM + ETINILESTRADIOLUM) MILLIGEST The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (NAPROXENUM + ESOMEPRAZOLUM) 500 mg/20 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (NETILMICINA + DEXAMETHASONUM) OPHTHALMIC DROPS, SOL. 3 mg/1 mg/ml - 5ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM) 10 mg/2,5 mg/1 0 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM) 10 mg/2,5 mg/5 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM) 5 mg/1,25 mg/1 0 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM) 5 mg/1,25 mg/5 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (PERINDOPRILUM + INDAPAMIDUM) 10 mg/2,5 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (PERINDOPRILUM + INDAPAMIDUM) 5 mg/1,25 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS (TOBRAMYCINUM + DEXAMETAZONUM) 3 mg/1 m g/g - 3.5 g OPHTHALMIC OINT. The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. COMBINATIONS CLENSIA POWDER FOR ORAL SUSPENSION The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. PROBIOTIC COMBINATIONS - REFFLOR FORTE 5-10*9 CFU The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ENTEROLACTIS-TYPE PROBIOTIC COMBINATIONS-LACTOBACILLUS PARACASEI DG, 8 BILLION LIVE CELLS, 10M SINGLE-DOSE VIAL The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Impregnated dressing 10 cm x 10 cm BIOTIDERMAL® The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Impregnated dressing 10 cm x 20 cm with BIOTITUS® Ointment -Original formula The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Impregnated dressing 10 cm x 20 cm BIOTIDERMAL® The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. BIOTITUS Regen Forte Cream - 50 ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. SILVER SULFADIAZINE CREAM 10 MG /G TUBE 50G The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Regen BIOTITUS® Cream - 50 ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. CYANOCOBALAMINUM 50 MG / ML 1 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DESLORATADINUM 0.5 mg/ ML 120 ML SYRUP The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DESMOPRESSINUM 120MICROGRAMS The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DESOGESTRELUM 0,075 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DEXAMETAZONA 20 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DEXMEDETOMIDINA 100 micrograms/ml CONC. FOR INF. SOL. 10 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DEXMEDETOMIDINA 100 micrograms/ml CONC. FOR INF. SOL. 4 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DEXTRANUM 40 + NaCl 500 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DIAZEPAMUM 10 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DICLOFENAC GEL 1% 50 G The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DINOPROSTONUM 10 MG / 24 HOURS (1 BOX = 1 VAGINAL DELIVERY SYSTEM) The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DIOSMECTITA 3G The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DOBUTAMINA HAMELN CONC. FOR INF. SOL. 12,5 mg/ml - 20 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. DTPA- kit required for renal scintigraphy The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ENALAPRILUM 10 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ENALAPRILUM 5 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. EPHEDRINI HYDROCHLORIDUM 50 mg/ml 1 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. EPTACOG ALFA ACTIVATUM POWDER + SOLVENT FOR INJ. SOL. 50 KIU 1 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ERDOSTEINUM 175mg/5ml -100 ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. ESOMEPRAZOLUM 40 mg The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. HUMAN FIBRINOGEN POWDER FOR INJ./INF. SOL. 1g The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. FLUMAZENILUM 0,1 mg/ml 5 ml The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. FLUOXETINUM 20 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. FLUPENTHIXOLUM 20 MG/ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. GABAPENTINUM 100 MG The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. GADOPICLENOLUM 0,5mmol/ml SOL. INJ. 15 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. GADOPICLENOLUM 0,5mmol/ml SOL. INJ. 30 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. GADOPICLENOLUM 0,5mmol/ml SOL. INJ. 7.5 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. GADOTERIDOLUM 0,5mmol/ml SOL. INJ. 15 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. GADOTERIDOLUM 0,5mmol/ml SOL. INJ. 20 ML The minimum and maximum quantities/framework agreement and for the subsequent contracts are set out in the Annex to the Tender Specifications. Procedure: open. Estimated value: 26,975,026.8 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.